Eric D. Donnenfeld, MD Presents 24 Months Grail Study Outcomes of the Juvene® IOL at the American Academy of Ophthalmology

AAO:  October 1, 2022 A Look at a New Shape-Changing IOL

Eric D. Donnenfeld, MD, shares the long-term refractive and contrast sensitivity outcomes of a clinical trial evaluating a novel accommodating, shape-changing IOL:


Recent News